PS127 Compounds Expose an AML Redox Vulnerability

Institutions: Rice University / MD Anderson Cancer Center · Compound Class: PS127 Series · Indication: Acute Myeloid Leukemia · Stage: Preclinical (Ex Vivo) · Date: August 28, 2026 Summary Researchers at Rice University and MD Anderson Cancer Center identified a class of PS127 compounds through…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Ipsen Acquires Kartos Therapeutics for Up to $1.75B
Kuva Merger Collapse Forces Lisata Therapeutics Retrenchment
Gilead – $5B Tubulis Acquisition
Scribe Sets Terms for a $100 Million IPO